Immune Senescence And Dormant Tumor Cells: Reconceptualizing Breast Cancer Recurrence As An Affliction Of Aging And Chronic Inflammation
Many breast cancer survivors live with the concern that their cancer might return, sometimes years after their initial treatment. Recent research suggests that this recurrence isn’t a random event but is often linked to two key factors: the natural aging of our immune system and ongoing, low-level inflammation in the body. As we get older, our immune system, which is crucial for fighting off diseases, becomes less effective—a process known as immune senescence. This means it’s not as vigilant in keeping any remaining cancer cells in check. Meanwhile, some cancer cells can survive initial treatments and enter a “dormant” or “sleeping” state, remaining inactive and undetectable for long periods. The critical insight is that chronic inflammation—a persistent, low-grade inflammatory response throughout the body—can act as a “wake-up call” for these dormant cancer cells. This inflammation, often associated with aging, creates an environment that encourages these sleeping cells to reactivate, begin multiplying, and form new tumors, leading to the cancer’s return. This new understanding of how an aging immune system and chronic inflammation contribute to the awakening of dormant cancer cells opens up promising new avenues for preventing breast cancer recurrence. Future strategies could focus on bolstering the immune system in older patients or reducing chronic inflammation to keep those dormant cells inactive for good.
Source: link to paper